Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yancheng Kaili Pharmaceutical is a specialized pharmaceutical manufacturer based in Yancheng, Jiangsu Province, China. The company focuses on the research, development, and large-scale production of Active Pharmaceutical Ingredients (APIs) and high-end pharmaceutical intermediates. Their core product portfolio is centered on metabolic health, particularly widely-used antidiabetic medications such as Metformin Hydrochloride and various sulfonylureas like Gliclazide. Yancheng Kaili operates GMP-compliant facilities and serves as a contract manufacturing partner for global pharmaceutical firms, exporting products to international markets including Europe and Southeast Asia. The company is a significant contributor to the global supply chain for small molecule chemical synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yancheng Kaili Pharmaceutical.